ResMed Inc
(BSP:R1MD34)
R$
368.7
0.14 (0.04%)
Market Cap: 216.49 Bil
Enterprise Value: 218.91 Bil
PE Ratio: 32.69
PB Ratio: 6.97
GF Score: 87/100 Resmed Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022 / 08:20PM GMT
Release Date Price:
R$256.88
(-1.01%)
Chris Cooper
Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. Good afternoon, everyone. For the next session, we are fortunate to be joined by Mick Farrell, the CEO of ResMed. Most of you will know they are a leading player in sleep and respiratory health globally. Thanks for joining us, Mick.
Michael J. Farrell
ResMed Inc. - CEO & Director
Happy to be here. Thanks for having me.
Questions & Answers
Chris Cooper
Goldman Sachs Group, Inc., Research Division - Research Analyst
Let's get straight into it. So overnight, you announced a $1 billion acquisition. Unfortunately, many of us here would have missed the call that you hosted this morning. Perhaps you could just run us through the final points and contextualize the German business for us and walk us through the value proposition.
Michael J. Farrell
ResMed Inc. - CEO & Director
Yes, absolutely. And we didn't intend M&A goes at the speed it goes. We didn't intend to -- for
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot